The current stock price of IDXX is 725.91 USD. In the past month the price increased by 13.27%. In the past year, price increased by 73.98%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.67 | 222.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.23 | 201.33B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.55B | ||
| SYK | STRYKER CORP | 27.96 | 140.79B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.98B | ||
| RMD | RESMED INC | 25.33 | 36.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.66 | 34.90B | ||
| DXCM | DEXCOM INC | 32.38 | 23.62B | ||
| PODD | INSULET CORP | 72.47 | 23.31B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.39 | 18.26B | ||
| HOLX | HOLOGIC INC | 17.41 | 16.54B |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE 04092 US
CEO: Jonathan J. Mazelsky
Employees: 11000
Phone: 12075560300
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
The current stock price of IDXX is 725.91 USD. The price increased by 5.3% in the last trading session.
IDXX does not pay a dividend.
IDXX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
IDXX stock is listed on the Nasdaq exchange.
IDEXX LABORATORIES INC (IDXX) currently has 11000 employees.
You can find the ownership structure of IDEXX LABORATORIES INC (IDXX) on the Ownership tab.
ChartMill assigns a technical rating of 10 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is one of the better performing stocks in the market, outperforming 93.37% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to IDXX. IDXX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 12.61. The EPS increased by 15.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.65% | ||
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| Debt/Equity | 0.53 |
22 analysts have analysed IDXX and the average price target is 773.18 USD. This implies a price increase of 6.51% is expected in the next year compared to the current price of 725.91.
For the next year, analysts expect an EPS growth of 14.37% and a revenue growth 9.1% for IDXX